These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9480496

  • 21. Tolerance development during transdermal administration of nitroglycerin in angina pectoris.
    Rehnqvist N.
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 6():113-5. PubMed ID: 3098045
    [Abstract] [Full Text] [Related]

  • 22. [A trial of the use of the transdermal preparation Deponit for treating stenocardia].
    Alliluev IG, Pecherskaia MB, Poltavskaia MG, Syrkin AL.
    Ter Arkh; 1996; 68(6):55-8. PubMed ID: 8771688
    [No Abstract] [Full Text] [Related]

  • 23. [Nitrates at high altitude, that is the inappropriate use of a drug].
    Donegani E.
    G Ital Cardiol (Rome); 2011 Dec; 12(12):824-8. PubMed ID: 22158453
    [No Abstract] [Full Text] [Related]

  • 24. [Transdermal application of nitroglycerin in the treatment of angina pectoris].
    Koster RW.
    Ned Tijdschr Geneeskd; 1985 Dec 14; 129(50):2389-90. PubMed ID: 3937062
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nitrate therapy: continuous or pulse dosing.
    Thadani U, Whitsett TL.
    Ration Drug Ther; 1987 Jul 14; 21(7):1-6. PubMed ID: 3124208
    [No Abstract] [Full Text] [Related]

  • 27. [Glyceryl trinitrate].
    Hinz B, Schröder H.
    Dtsch Med Wochenschr; 1997 Aug 22; 122(34-35):1047-8. PubMed ID: 9312460
    [No Abstract] [Full Text] [Related]

  • 28. Time course of the interaction between tadalafil and nitrates.
    Abrams J.
    J Am Coll Cardiol; 2004 Jun 02; 43(11):2150; author reply 2150-1. PubMed ID: 15172433
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris.
    Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A.
    J Am Coll Cardiol; 1997 Apr 02; 29(5):941-7. PubMed ID: 9120179
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Allergic contact dermatitis from nitroglycerin contained in 2 transdermal systems.
    Machet L, Martin L, Toledano C, Jan V, Lorette G, Vaillant L.
    Dermatology; 1999 Apr 02; 198(1):106-7. PubMed ID: 10026420
    [No Abstract] [Full Text] [Related]

  • 33. Potential problems with intermittent nitrate therapy.
    Parker JD.
    Can J Cardiol; 1996 May 02; 12 Suppl C():22C-24C. PubMed ID: 8634920
    [Abstract] [Full Text] [Related]

  • 34. Keeping track of the patch: transdermal delivery in obese patients.
    McErlane K.
    Am J Nurs; 2005 Jun 02; 105(6):36-7. PubMed ID: 15930866
    [No Abstract] [Full Text] [Related]

  • 35. Cutaneous administration of nitroglycerin: a review.
    Olivari MT, Cohn JN.
    Pharmacotherapy; 1983 Jun 02; 3(3):149-57. PubMed ID: 6410359
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Nitroglycerin patches: properties and norms for correct use].
    Soler Climent E.
    Rev Enferm; 1998 Dec 02; 21(244):74-8. PubMed ID: 10076472
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA, Breaux PC, Ibrahim F.
    Clin Ther; 1985 Dec 02; 8(1):30-4. PubMed ID: 3938681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.